Study shows promising outcomes of new mitral valve replacement procedure in high-risk patients
An innovative mitral valve replacement procedure shows promise for high-risk patients in a new University of Miami Miller School of Medicine study led by Joseph Lamelas, M.D., chief and program director of cardiothoracic surgery.
Limited surgical treatments are available for high-risk patients with severe mitral annular calcification, a hardening of the ring at the base of the valve. Our team has achieved good outcomes with a minimally invasive transcatheter aortic valve prosthesis in the mitral valve position (MVR-TAVR)."
Dr. Joseph Lamelas, M.D., Chief and Program Director of Cardiothoracic Surgery